Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Nanotechnology Programs at FDA

Nanotechnology Programs at FDA

                        Nanotechnology Guidance Documents
          Nanotechnology Task Force Home
          Science & Research
          Science and Research Special Topics
          Nanotechnology Programs at FDA
          Center for Biologics Evaluation and Research Nanotechnology ProgramsNanotechnology Programs at FDA Center for Biologics Evaluation and Research Nanotechnology Programs
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe Center for Biologics Evaluation and Research (CBER) conducts active mission-related regulatory science research programs in order to provide effective regulatory review of biological products. This research greatly expands our knowledge of fundamental biological processes and provides a strong scientific base for regulatory review.The following provides information on regulatory science research programs in nanotechnology being conducted at CBER.**Novel detection technologies for pathogen detection**The goals of our work are to: 1) develop new, improved diagnostic tools for testing blood and plasma and rapidly detecting emerging pathogens that threaten public health; and 2) provide FDA product reviewers with improved scientific understanding of novel technologies, including those relying on use of nanomaterials, that might be applied by manufacturers, enhancing the review and evaluation of new diagnostic tests for blood-borne pathogens and bioterrorism agents. For more information, see: Improving Safety of the Blood Supply from Transmission of HIV/AIDS and Other Emerging Blood Borne Viral and Biodefense Agents by Developing Sensitive Diagnostic Tools and Investigating Disease Pathogenesis.**Blood Safety**The focus of this work is on the effects of various commercially-available carbon nanomaterials on blood cells and platelets and on vessel wall cells grown in tissue cultures. This research will help FDA to evaluate the safety and effectiveness of carbon nanomaterials in biomedical applications. For more information, see: Investigation of Potential Toxic Effects of Engineered Nanoparticles and Biologic Microparticles in Blood and Their Biomarker Applications.For further information:Consumer Affairs Branch (CBER)Division of Communication and Consumer AffairsOffice of Communication, Outreach and DevelopmentFood and Drug Administration1401 Rockville PikeSuite 200N/HFM-47Rockville, MD 20852-1448Telephone: 1-800-835-4709Email: ocod@fda.hhs.gov

                                                                                  Content current as of:
      03/19/2018Nanotechnology Programs at FDA

          
                        Nanotechnology Guidance Documents
          Nanotechnology Task Force
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop